Cencora Shares Climb 0.84% on Strategic Healthcare Partnership, Rank 347th in $0.33 Billion Daily Volume

On October 6, 2025, Cencora (COR) closed with a 0.84% gain, trading at a daily volume of $0.33 billion, ranking 347th among listed equities. The stock’s performance was influenced by strategic developments in its healthcare supply chain operations, including a recent partnership to enhance drug distribution efficiency. Analysts noted that the agreement could stabilize revenue streams amid ongoing industry cost pressures.

Market observers highlighted the stock’s resilience despite broader sector volatility, citing improved operational metrics reported in the prior quarter. The company’s focus on optimizing inventory management and expanding its network of distribution centers has drawn investor attention. However, concerns about macroeconomic headwinds, particularly inflationary pressures on healthcare spending, remain a key risk factor.

To execute a back-test for “buying the top 500 stocks by daily trading volume, holding for one day, from 2022-01-01 to today,” several parameters must be clarified. The universe definition requires specifying whether U.S.-listed equities (NYSE + NASDAQ) are included and whether micro-caps should be excluded to avoid illiquid names. Rebalancing logic typically involves ranking stocks by trading volume after day t’s close, forming an equal-weight portfolio of the top 500, and holding it for the next trading day. Transaction costs and slippage assumptions, such as 2 basis points per trade, also need confirmation. The current back-test engine processes one instrument at a time, necessitating an aggregated portfolio analysis offline before visualization. Finalizing these details will enable data retrieval and performance reporting.